Perpetua Medical AB Income Statement

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	13.57	6.94	9.94	10.11	8.82	1.9
Revenue Growth (YoY)	153.97%	-30.16%	-1.76%	14.73%	363.72%	-12.86%
Cost of Revenue	6.72	3.8	4.09	3.47	2.89	0.96
Gross Profit	6.85	3.14	5.85	6.65	5.93	0.94
Selling, General & Admin	11.32	10.94	23.78	25.56	19.37	15.73
Other Operating Expenses	-10.84	-5.66	0.38	-0.19	-0.14	-0.77
Operating Expenses	1.99	5.6	24.34	25.76	19.61	15.46
Operating Income	4.86	-2.46	-18.49	-19.11	-13.68	-14.51
Interest Expense	-0.42	-0.08	-0.07	-0.13	-0.15	-0.15
Interest & Investment Income	0.09	0.29	0.29	0.07	0.12	0.07
Earnings From Equity Investments	-0.23	-	-	-	-	-
Other Non Operating Income (Expenses)	-0	-	-	-0	-	-
EBT Excluding Unusual Items	4.3	-2.24	-18.28	-19.16	-13.71	-14.59
Gain (Loss) on Sale of Assets	0.04	0.04	-	-	-	-
Pretax Income	4.34	-2.2	-18.28	-19.16	-13.71	-14.59
Income Tax Expense	0.43	0.18	-	-	-	-
Earnings From Continuing Operations	3.91	-2.38	-18.28	-19.16	-13.71	-14.59
Minority Interest in Earnings	0.05	-0.09	-	-	-	-
Net Income	3.96	-2.47	-18.28	-19.16	-13.71	-14.59
Net Income to Common	3.96	-2.47	-18.28	-19.16	-13.71	-14.59
Shares Outstanding (Basic)	5	4	2	1	1	0
Shares Outstanding (Diluted)	5	4	2	1	1	0
Shares Change (YoY)	18.80%	145.32%	153.20%	20.61%	20.91%	31.09%
EPS (Basic)	0.87	-0.58	-10.56	-28.03	-24.18	-31.11
EPS (Diluted)	0.87	-0.58	-10.56	-28.03	-24.18	-31.11
Free Cash Flow	-4.01	-7.03	-16.41	-19.65	-15.84	-13.58
Free Cash Flow Per Share	-0.89	-1.66	-9.48	-28.74	-27.94	-28.95
Gross Margin	50.50%	45.27%	58.85%	65.72%	67.26%	49.68%
Operating Margin	35.82%	-35.39%	-186.11%	-188.94%	-155.22%	-763.45%
Profit Margin	29.16%	-35.64%	-183.94%	-189.48%	-155.54%	-767.33%
Free Cash Flow Margin	-29.57%	-101.27%	-165.16%	-194.31%	-179.68%	-714.17%
EBITDA	6.37	-2.13	-18.31	-18.72	-13.3	-14.01
EBITDA Margin	46.93%	-30.73%	-184.31%	-185.10%	-150.87%	-
D&A For EBITDA	1.51	0.32	0.18	0.39	0.38	0.5
EBIT	4.86	-2.46	-18.49	-19.11	-13.68	-14.51
EBIT Margin	35.82%	-35.39%	-186.11%	-188.94%	-155.22%	-
Revenue as Reported	25.06	14.15	9.98	10.42	9	2.77

Source: S&P Global Market Intelligence. Standard template. Financial Sources.